Key result
RIPK1 is cleaved by the 3C protease across diverse Rhinovirus strains, a process that is abrogated by the specific 3C protease inhibitor Rupintrivir.
Why the study?
Having previously shown that RVA-16 3C protease cleaves RIPK1, the authors investigated whether this cleavage is conserved across selected RV strains.
The 3C protease from diverse Rhinovirus strains cleaves RIPK1, suggesting this mechanism is conserved and important for the viral lifecycle.
Rupintrivir may modulate rhinovirus effects on cell death; hypothesis-generating for host-targeted antivirals, with no current clinical implications.
Rhinoviruses (RV), like many other viruses, modulate programmed cell death to their own advantage. The viral protease, 3C has an integral role in the modulation, and we have shown that RVA-16 3C protease cleaves Receptor-interacting protein kinase-1 (RIPK1), a key host factor that modulates various cell death and cell survival pathways. In the current study, we have investigated whether this cleavage is conserved across selected RV strains. RIPK1 was cleaved in cells infected with strains representing diversity across phylogenetic groups (A and B) and receptor usage (major and minor groups). The cleavage was abrogated in the presence of the specific 3C protease inhibitor, Rupintrivir. Interestingly, there appears to be involvement of another protease (maybe 2A protease) in RIPK1 cleavage in strains belonging to genotype B. Our data show that 3C protease from diverse RV strains cleaves RIPK1, highlighting the importance of the cleavage to the RV lifecycle.
No takes yet. Share an insight, caveat, or question.
Croft et al. (2021) studied Rhinovirus infection. Rhinovirus strains (groups A and B) was evaluated on RIPK1 cleavage. RIPK1 is cleaved by the 3C protease across diverse Rhinovirus strains, a process that is abrogated by the specific 3C protease inhibitor Rupintrivir.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: